Long-term efficacy and safety of modafinil (PROVIGIL®) for the treatment of excessive daytime sleepiness associated with narcolepsy
- 1 July 2000
- journal article
- Published by Elsevier in Sleep Medicine
- Vol. 1 (3) , 231-243
- https://doi.org/10.1016/s1389-9457(00)00031-9
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Randomized trial of modafinil as a treatment for the excessive daytime somnolence of narcolepsyNeurology, 2000
- Narcolepsy: Signs, Symptoms, Differential Diagnosis, and ManagementArchives of Family Medicine, 1998
- Randomized trial of modafinil for the treatment of pathological somnolence in narcolepsyAnnals of Neurology, 1998
- DQB1*0602 and DQA1*0102 (DQ1) Are Better Markers Than DR2 for Narcolepsy in Caucasian and Black AmericansSleep, 1994
- Evaluation of Treatment With Stimulants in NarcolepsySleep, 1994
- Epidemiology of NarcolepsySleep, 1994
- FAMILIAL PATTERNS OF NARCOLEPSYThe Lancet, 1989
- Guidelines for the Multiple Sleep Latency Test (MSLT): A Standard Measure of SleepinessSleep, 1986
- Narcolepsy-CataplexyArchives of Neurology, 1982
- Life Effects of Narcolepsy in 180 Patients from North America, Asia and Europe Compared to Matched ControlsCanadian Journal of Neurological Sciences, 1981